BT Slingsby First Malaria World Congress 2018

BT Slingsby

Dr. Slingsby is CEO & Executive Director of the GHIT Fund — the World's first public-private fund focused on the development of new medicines for low- and middle-income countries. Previously, he was the global head for access strategies at Eisai Co., Ltd. where he developed new business models for R&D and overlooked market access in the developing world. Dr. Slingsby has helped launch numerous start-ups in Japan and the U.S., and currently advises at the Graduate School of Medicine at the University of Tokyo and Kyoto University. He is a member of the Public-Private Partnership Forum at the National Academy of Medicine in the U.S. and the Global Health and Human Security Program, and has published over 50 peer-reviewed articles on medicine and public health in both Japanese and, American literature. Dr. Slingsby graduated from Brown University, earned his Masters and Doctorate from Kyoto University, and the University of Tokyo, and received his Medical Doctorate from the George Washington University.